Summit Therapeutics (SMMT.MX) Q2 2025 Earnings

1MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.82
-1.54
-1.26
-0.98

Details

Expected EPS
-1.8222794176
Actual EPS
-1.7631359999999998
Surprise EPS
0.06
Surprise Percent
+3.25%

Description

Summit Therapeutics (SMMT.MX) has reported earnings of -1.7631359999999998 per share for Q2 2025.

0 Comments

Share your thoughts